Balt’s Squid liquid embolic receives US FDA approval for adjunctive treatment for chronic subdural hematomas: Boston Friday, February 6, 2026, 17:00 Hrs [IST] Balt Inc, a global ...

Balt, Inc., a global technology leader in neurovascular devices, today announced the Premarket Approval (PMA) of the Squid(TM) liquid embolic agent. Squid is approved for the embolization of the ...

Balt, Inc., a global technology leader in neurovascular devices, today announced the Premarket Approval (PMA) of the Squid liquid embolic agent. Squid is approved ...

CSF leaks are frequently misdiagnosed as migraines or sinus infections. Experts at Cedars-Sinai note that because symptoms often overlap with more common conditions, CSF leaks are frequently ...

1 Scruton TJ. Updates on the diagnosis and management of subdural hematoma. JAAPA. 2024;37(8):9-15. 2 McBride W. Subdural hematoma in adults: Etiology, clinical features, and diagnosis. Waltham: ...

1. Across 18 U.S. centers, preference for surgical or conservative management for acute subdural hematoma (ASDH) varied widely but did not affect six-month functional outcomes. Evidence Rating Level: ...

Earlier this month, Medtronic received a new approval from the FDA for its decades-old liquid embolic system, extending its use to treat certain kinds of internal brain bleeds. Now, Johnson & Johnson ...

In the early 1990s when I was a young pediatrician, I was responsible for evaluating children with developmental and learning problems. Two unrelated boys, ages 7 and 9, were found to have IQs in the ...

- TRUFILL n-BCA is now indicated for embolization of the middle meningeal artery (MMA) for the treatment of symptomatic subacute and Chronic Subdural Hematoma (cSDH) as an adjunct to surgery. - ...